Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2005 | 04-2005 | 01-2005 | 10-2004 | 07-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 88,800 | 48,900 | 14,100 | 31,600 | 18,000 |
| Depreciation Amortization | 41,400 | 27,300 | 13,900 | 40,900 | 28,900 |
| Income taxes - deferred | N/A | N/A | 600 | 1,900 | N/A |
| Accounts receivable | -48,400 | -46,700 | 15,900 | -7,000 | 8,600 |
| Accounts payable and accrued liabilities | 3,500 | 10,500 | -1,200 | 800 | -1,700 |
| Other Working Capital | -105,800 | -86,100 | -33,000 | 10,700 | -14,300 |
| Other Operating Activity | 28,400 | 29,200 | -26,600 | -71,000 | -58,400 |
| Operating Cash Flow | $7,900 | $-16,900 | $-16,300 | $7,900 | $-18,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 93,800 |
| PPE Investments | -2,700 | 6,200 | -1,500 | -3,200 | 400 |
| Net Acquisitions | 26,600 | 33,700 | 33,600 | -227,300 | -288,700 |
| Purchase Of Investment | -734,300 | -561,100 | -270,900 | -2,073,200 | N/A |
| Sale Of Investment | 704,400 | 555,400 | 278,700 | 2,115,900 | N/A |
| Other Investing Activity | 23,500 | 11,800 | -3,000 | -4,600 | -4,200 |
| Investing Cash Flow | $17,500 | $46,000 | $36,900 | $-192,400 | $-198,700 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | -10,700 | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -10,200 |
| Common Stock Issued | 11,400 | 2,400 | 900 | 3,700 | 3,300 |
| Financing Cash Flow | $11,400 | $2,400 | $900 | $-7,000 | $-6,900 |
| Exchange Rate Effect | -1,300 | 1,900 | 200 | -200 | -900 |
| Beginning Cash Position | 63,800 | 66,200 | 66,200 | 255,500 | 285,600 |
| End Cash Position | 99,300 | 99,600 | 87,900 | 63,800 | 60,200 |
| Net Cash Flow | $35,500 | $33,400 | $21,700 | $-191,700 | $-225,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,900 | -16,900 | -16,300 | 7,900 | -18,900 |
| Capital Expenditure | -19,400 | -10,500 | -4,600 | -14,400 | -10,400 |
| Free Cash Flow | -11,500 | -27,400 | -20,900 | -6,500 | -29,300 |